WHO ICTRP trial
ENact-PD: EEG Neuro-feedback to improve motor function in Parkinson’s
ISRCTN16783092 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN16783092 |
|---|---|
| Public title | ENact-PD: EEG Neuro-feedback to improve motor function in Parkinson’s |
| Scientific title | A feasibility trial of the effects of home-based alpha frequency neurofeedback in modulating cortical activity and alleviating motor symptoms in Parkinson’s disease |
| Primary sponsor | Betsi Cadwaladr University Health Board |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | United Kingdom;Wales |
| Conditions | Parkinson's Disease Nervous System Diseases Parkinson's Disease |
| Interventions | Current intervention as of 04/08/2023: We will employ a fully within-subjects design. Each participant will receive six home visits from a researcher, with each visit separated by a minimum of 48 hours. There are two distinct phases of the… |
| Registration date | Aug 29, 2017 |
| Target size | 9 |
| Secondary IDs | ENact-PD version 1 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: